KalVista Pharmaceuticals, Inc.
KALVDelisted Jun 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348911
KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.
Q2 2024 vs. Q1 2024
How the institutions holding KalVista Pharmaceuticals, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 129 | 119 | −10 |
| Shares | 47.0M | 48.2M | +1.25M (+2.7%) |
| Value | $557.2M | $568.2M | +$11.0M (+2.0%) |
New holders (19)
Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Great Point Partners LLC | 1,338,568 | $15.8M | 3.02% |
| Norges Bank | 131,300 | $1.55M | 0.00% |
| Russell Investments Group, Ltd. | 78,682 | $926.9K | 0.00% |
| Corton Capital Inc. | 39,593 | $466.4K | 0.24% |
| Advisor Group Holdings, Inc. | 21,380 | $251.9K | 0.00% |
| Corebridge Financial, Inc. | 20,489 | $241.4K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 16,270 | $191.7K | 0.00% |
| Evoke Wealth, LLC | 15,373 | $181.1K | 0.27% |
| Verition Fund Management LLC | 15,113 | $178.0K | 0.00% |
| nVerses Capital, LLC | 2,100 | $24.7K | 0.01% |
| 1620 Investment Advisors, Inc. | 1,590 | $18.7K | 0.01% |
| Smartleaf Asset Management LLC | 79 | $951 | 0.00% |
| Lindbrook Capital, LLC | 39 | $459 | 0.00% |
| Innealta Capital, LLC | 30 | $353 | 0.00% |
| Creekmur Asset Management LLC | 23 | $271 | 0.00% |
| The PNC Financial Services Group, Inc. | 19 | $224 | 0.00% |
| Farther Finance Advisors, LLC | 13 | $155 | 0.00% |
| Rothschild Investment LLC | 10 | $118 | 0.00% |
| CWM, LLC | 30 | $0 | 0.00% |
Sold out (29)
Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.